Skip to main content
博迅生物 logo

博迅生物 — Investor Relations & Filings

Ticker · 920504 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 301 across all filing types
Latest filing 2025-03-05 Capital/Financing Update
Country CN China
Listing Beijing Stock Exchange 920504

About 博迅生物

http://www.boxun.com.cn/

Boxun Medical Biological Instrument Corp. specializes in the development and manufacture of laboratory equipment and medical instruments. The company's core product line includes high-pressure steam sterilizers, constant temperature incubators, CO2 incubators, drying ovens, and environmental test chambers. These instruments are designed for applications in life sciences, healthcare, pharmaceutical research, and environmental monitoring. Boxun focuses on delivering precise thermal control and reliable sterilization solutions, ensuring compliance with international quality standards. Its equipment is utilized in scientific research, clinical diagnostics, and industrial quality control to maintain sterile environments and stable experimental conditions. The company emphasizes technical innovation and product durability to support the requirements of modern laboratory facilities.

Recent filings

Filing Released Lang Actions
关于使用闲置自有资金购买理财产品的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Shanghai Boxun Medical Biological Instruments Co., Ltd. regarding the use of idle proprietary funds to purchase financial products. It details the purpose, amount, method, duration, decision-making process, risk analysis, and impact on the company. The document is short (1326 characters) and focuses on a financing activity involving the company's capital allocation to financial products. It is not a full financial report, audit, or earnings release. It is not a regulatory filing or report publication announcement since it contains substantive information about the financing decision. The content fits best under Capital/Financing Update (CAP) as it updates on the company's financing activities and capital usage.
2025-03-05 Chinese
国金证券股份有限公司关于上海博迅医疗生物仪器股份有限公司预计2025年日常性关联交易的专项核查意见
Regulatory Filings Classification · 95% confidence The document is a specialized verification opinion from a sponsoring securities company regarding the expected 2025 routine related-party transactions of Shanghai Boxun Medical Biological Instruments Co., Ltd. It includes details about the nature, pricing, necessity, and approval procedures of these related-party transactions. The document is regulatory in nature, focusing on compliance with securities issuance and listing rules, and does not contain financial statements or comprehensive financial performance data. It is not an annual or interim report, nor an earnings release or management discussion. It is also not a simple announcement or a proxy solicitation. Given the detailed regulatory compliance and verification content, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory compliance documents that do not fit other specific categories. The document length is short (2160 characters), and it is not merely an announcement of a report but a substantive regulatory opinion document. Therefore, the classification is RNS with high confidence.
2025-03-05 Chinese
关于预计2025年日常性关联交易的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the company's expected related party transactions for the year 2025. It details the nature of the transactions, the parties involved, the approval process by the board and independent directors, and the fairness of pricing. It does not contain financial statements or detailed financial performance data. The document is a regulatory announcement about related party transactions, which fits best under the category of Regulatory Filings (RNS) as it is a compliance disclosure rather than a financial report or a specific transaction type like capital changes or management changes.
2025-03-05 Chinese
关于使用闲置募集资金进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Shanghai Boxun Medical Biological Instruments Co., Ltd. regarding the use of idle raised funds for cash management. It details the amount of funds raised, their usage, storage, and the decision to invest idle funds in low-risk financial products. It includes opinions from the supervisory board and the sponsoring institution, confirming compliance with relevant regulations and no adverse impact on shareholders. The document is a formal disclosure about the company's capital management activities related to fundraising proceeds, not a full financial report or earnings release. It fits the category of Capital/Financing Update (CAP) as it updates on the use and management of raised capital funds.
2025-03-05 Chinese
国金证券股份有限公司关于上海博迅医疗生物仪器股份有限公司使用部分暂时闲置募集资金进行现金管理的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed report from the sponsor institution (Guojin Securities Co., Ltd.) regarding the use of temporarily idle raised funds by Shanghai Boxun Medical Biological Instruments Co., Ltd. for cash management. It includes specifics about the fundraising, usage, investment products, risk control, and approvals by the board and supervisory committee. The document is not an announcement of a report publication but a substantive verification and opinion report on the use of raised funds. It does not contain financial statements or quarterly results, so it is not an Annual Report (10-K) or Interim Report (IR). It is not a capital/financing update (CAP) in the sense of new fundraising but relates to the management of existing raised funds. The document is a formal audit or verification opinion on the use of raised funds, which fits best under Audit Report / Information (AR). The document length is under 5,000 characters but contains detailed content, not just an announcement or certification letter, so it is not RPA or RNS. Therefore, the best classification is AR with high confidence. Q1 2025
2025-03-05 Chinese
第四届董事会第四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the fourth meeting of the fourth board of directors of Shanghai Boxun Medical Biological Instruments Co., Ltd. It details the meeting's attendance, agenda items, voting results, and references to related announcements on the Beijing Stock Exchange information disclosure platform. The content focuses on board meeting decisions and governance matters, such as the use of idle funds and related party transactions. There is no financial data, earnings information, or report publication mentioned. The document is not a full report but an official announcement of board meeting resolutions, which fits the category of Board/Management Information (MANG). The document length is short (1573 characters), and it is not a report publication announcement or regulatory filing. Therefore, the classification is MANG with high confidence.
2025-03-05 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.